AQR Capital Management - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$3,271,000
+19.8%
21,635
+15.5%
0.01%
+33.3%
Q2 2022$2,730,000
+9.2%
18,737
-11.1%
0.01%
+20.0%
Q1 2022$2,500,000
-22.8%
21,081
-10.2%
0.01%
-16.7%
Q4 2021$3,237,000
-18.8%
23,488
-18.1%
0.01%
-14.3%
Q3 2021$3,984,000
+414.7%
28,683
+259.9%
0.01%
+600.0%
Q2 2021$774,000
-43.5%
7,970
-60.2%
0.00%
-50.0%
Q1 2021$1,369,000
-21.0%
20,027
-0.9%
0.00%
-33.3%
Q4 2020$1,733,000
+4.6%
20,217
-20.7%
0.00%0.0%
Q3 2020$1,657,000
+94.0%
25,487
+118.1%
0.00%
+200.0%
Q2 2020$854,000
-4.8%
11,685
-55.7%
0.00%
-50.0%
Q1 2020$897,000
+311.5%
26,370
+353.5%
0.00%
Q3 2018$218,0005,8150.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders